📊 Score Breakdown
Offering Ability
100
Cash Runway
95
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
73%
💰 Capital Raise
93%
• Critical: only 2.1 months cash remaining
• Active shelf registration ($50M, 849% of market cap)
🔁 Convertible Conversion
60%
• Major convertible overhang: 74% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
45%
• 50-day avg $1.89 approaching $1 threshold
• Only 2 months cash — financial pressure
💹 Market Data
Market Cap$5.89M
Shares Outstanding5.21M
Float4.57M
Cash$1.48M
Debt$2.48M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 29.9% shares (2025Q4 vs prior)
47 institutional holders · 4.47M shares
#1
VANGUARD GROUP INC
1.22M shares
#2
BlackRock, Inc.
482.4K shares
#3
GEODE CAPITAL MANAGEMENT, LLC
348.8K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest118.4K
Days to Cover1.0
% of Float2.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
424B5
ATM
May 01, 2026
8-K
8K EVENT
May 01, 2026
8-K
8K EVENT
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for FBLG
📊 FBLG FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 FBLG Signal Convergence & Dark Pool Activity — StonkWhisper
📄 FBLG Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.